Founders Capital Management (Texas)’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Founders Capital Management (Texas)’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,000	Closed	-$9K	–	327
2021 Q3	$9K	Buy	+3,000	New	+$10.7K	0.01%	281
2020 Q1	$13K	Sell	4,000 -1,000	-20%	-$5.27K	0.01%	194
2019 Q4	$23K	Buy	5,000 +1,400	+39%	+$4.43K	0.02%	167
2019 Q3	$15K	Hold	3,600	–	–	0.01%	212
2019 Q2	$14K	Hold	3,600	–	–	0.01%	231
2019 Q1	$15K	Hold	3,600	–	–	0.01%	217
2018 Q4	$9K	Hold	3,600	–	–	0.01%	248
2018 Q3	$26K	Sell	3,600 -400	-10%	-$1.75K	0.02%	161
2018 Q2	$15K	Hold	4,000	–	–	0.01%	222
2018 Q1	$15K	Hold	4,000	–	–	0.01%	244
2017 Q4	$14K	Hold	4,000	–	–	0.01%	250
2017 Q3	$16K	Buy	4,000 +2,000	+100%	+$9.18K	0.01%	230
2017 Q2	$10K	Buy	2,000 +1,600	+400%	+$8.99K	0.01%	280
2017 Q1	$3K	Buy	+400	New	+$3.13K	﹤0.01%	371

Other funds holding AGTC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Founders Capital Management (Texas)'s AGTC Position: Q4 2021 in Review

Founders Capital Management (Texas) sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2021, closing a stake of 3,000 shares — an estimated $9K sold.

Founders Capital Management (Texas) first reported a position in AGTC in Q1 2017 and held it in 14 quarters. The position peaked at $26K in Q3 2018. 55 funds tracked by Wall St. Rank hold AGTC as of Q4 2021.

Founders Capital Management (Texas) reported no remaining Applied Genetic Technologies Corporation position as of Q4 2021 after selling out during the quarter.
Founders Capital Management (Texas) sold 3,000 Applied Genetic Technologies Corporation shares in Q4 2021, an estimated $9K.
Founders Capital Management (Texas) first reported a position in Applied Genetic Technologies Corporation in Q1 2017 and held it in 14 quarters.
Founders Capital Management (Texas)'s Applied Genetic Technologies Corporation position peaked at $26K in Q3 2018.
55 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2021.

Based on Founders Capital Management (Texas)'s 13F filing for Q4 2021, filed 21 Jan 2022.